The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres
Abstract
Treatment of many intracellular infections in the mononuclear phagocytic system (MPS), requires targeting of antibiotics by a drug delivery system. The objective of this study was to examine whether the particular nature of microspheres, made of end-group capped and uncapped poly(lactide) [PLA] and poly(lactide-co-glycolide) [PLGA 50:50 and PLGA 75:25], affect the uptake into and also the activation of monocyte-macrophages. Placebo and gentamicin sulfate containing microspheres were incubated with J774 murine monocyte-macrophages and fresh human blood monocytes. Phagocytosis became more efficient with increasing polymer hydrophobicity, whereas opsonization of the particles in serum exerted inconsistent effects. Monocyte activation was determined by flow cytometry and measured as oxidative burst. The cellular oxidative burst induced by the particles was higher for end-group uncapped polymers. Opsonization increased significantly the oxidative activity of J774 monocytes, but affected inconsistently that of human blood monocytes. The results demonstrate that PLA and PLGA microspheres loaded with gentamicin sulfate were efficiently phagocytosed in vitro. The end-group uncapped polymer-type microspheres promoted significantly cell activation, which may be of importance for drug delivery and targeting to intracellular infections.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Particle structures smaller than 5 μm are taken up by APCs, such as dendritic cells (DCs) and macrophages [59–61], and are transported directly to the lymph node [58], where the encapsulated antigen can be presented to T cells.”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [60]
Citations
Cites
Hansen, M., Nielsen, S. E., & Berg, K. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90397-9 · Cited by 3,488
Krevelen, D. W. V. (1990) · Cited by 3,264
Silverstein, S. C., Steinman, R. M., & Cohn, Z. A. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.003321 · Cited by 1,290
Biodegradable polymers as drug delivery systems
(1992) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(92)90663-b · Cited by 777
Long circulating microparticulate drug carriers
Stolnik, S., Illum, L., & Davis, S. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00025-3 · Cited by 709
MTT colorimetric assay for testing macrophage cytotoxic activity in vitro
Ferrari, M., Fornasiero, M. C., & Isetta, A. M. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90187-z · Cited by 566
Biodegradable polymers as drug delivery systems
Zhao, L. (1991) · European Journal of Medicinal Chemistry · doi:10.1016/0223-5234(91)90162-g · Cited by 517
One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate
Okada, H. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00050-1 · Cited by 380
Roser, M., Fischer, D., & Kissel, T. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00038-1 · Cited by 368
Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption
Gessner, A., Waicz, R., Lieske, A., Paulke, B. ‐., Mäder, K., & Müller, R. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00432-9 · Cited by 358
Research works printed but not linked: 1
- Müller, R.H., 1991. Modification of drug carriers. In: Müller, R.H. (Ed.), Colloidal Carriers for Controlled Drug Delivery and Targeting. Wissenschaftliche Verlagsgesellschaft, Stuttgart, CRC Press, Boca Raton, FL, pp. 19–97.
Cited by
Sorted by citations
Nanoparticles for drug delivery: The need for precision in reporting particle size parameters
Gaumet, M., Vargas, A., Gurny, R., & Delié, F. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.001 · Cited by 1,117
PLGA-Based Nanoparticles as Cancer Drug Delivery Systems
Mirakabad, F. S. T., Nejati‐Koshki, K., Akbarzadeh, A., Yamchi, M. R., Milani, M., Zarghami, N., Zeighamian, V., Rahimzadeh, A., Alimohammadi, S., Hanifehpour, Y., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.2.517 · Cited by 553
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
Dinarvand, R., Sepehri, N., Manouchehri, Rouhani, & Atyabi, F. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s18905 · Cited by 468
Formulation aspects of biodegradable polymeric microspheres for antigen delivery
Tamber, H., Johansen, P., Merkle, H. P., & Gander, B. A. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.002 · Cited by 318
Self-citationPhysico-chemical features of engineered nanoparticles relevant to their toxicity
Fubini, B., Ghiazza, M., & Fenoglio, I. (2010) · Nanotoxicology · doi:10.3109/17435390.2010.509519 · Cited by 297
Pierigè, F., Serafini, S., Rossi, L., & Magnani, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.029 · Cited by 296
Joubert, M. K., Hokom, M. M., Eakin, C. M., Zhou, L., Deshpande, M., Baker, M., Goletz, T. J., Kerwin, B. A., Chirmule, N., Narhi, L. O., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.330902 · Cited by 268
Delivery systems to increase the selectivity of antibiotics in phagocytic cells
Briones, E., Colino, C. I., & Lanao, J. M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.027 · Cited by 226
Thiele, L., Merkle, H. P., & Walter, E. (2003) · Pharmaceutical Research · doi:10.1023/a:1022271020390 · Cited by 183
Self-citationHirota, K., Hasegawa, T., Hinata, H., Ito, F., Inagawa, H., Kochi, C., Soma, G., Makino, K., & Terada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.013 · Cited by 182
Inhaled drug therapy for treatment of tuberculosis
Misra, A., Hickey, A. J., Rossi, C. R., Borchard, G., Terada, H., Makino, K., Fourie, P. B., & Colombo, P. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.08.009 · Cited by 174
Konan, Y. N., Berton, M., Gurny, R., & Allémann, É. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00017-4 · Cited by 161
Brezden, A., Mohamed, M. F., Nepal, M., Harwood, J. S., Kuriakose, J., Seleem, M. N., & Chmielewski, J. A. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b04831 · Cited by 160
Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting
Gupta, U. D., & Jain, N. K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.018 · Cited by 156
Nanomedicine: Novel approaches in human and veterinary therapeutics
Irache, J. M., Esparza, I., Gamazo, C., Agüeros, M., & Espuelas, S. (2011) · Veterinary Parasitology · doi:10.1016/j.vetpar.2011.05.028 · Cited by 154
Self-citationCellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives.
Françoise Van Bambeke, A., Barcia-Macay, M., Lemaire, S., & Tulkens, P. M. (2006) · PubMed · Cited by 138
Drug loading and release on tumor cells using silk fibroin–albumin nanoparticles as carriers
Subia, B., & Kundu, S. C. (2012) · Nanotechnology · doi:10.1088/0957-4484/24/3/035103 · Cited by 136
Gheysoori, P., Paydayesh, A., Jafari, M. T., & Peidayesh, H. (2023) · European Polymer Journal · doi:10.1016/j.eurpolymj.2023.111846 · Cited by 120
Jilek, S., Merkle, H. P., & Walter, E. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.010 · Cited by 119
Self-citationNominally identical microplastic models differ greatly in their particle-cell interactions
Wieland, S., Ramsperger, A. F. R. M., Gross, W., Lehmann, M., Witzmann, T., Caspari, A., Obst, M., Gekle, S., Auernhammer, G. K., Fery, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45281-4 · Cited by 114
Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain
Milligan, E. D., Soderquist, R. G., Malone, S. M., Mahoney, J. H., Hughes, T., Langer, S. J., Sloane, E. M., Maier, S. F., Leinwand, L. A., Watkins, L. R., et al. (2006) · Neuron Glia Biology · doi:10.1017/s1740925x07000488 · Cited by 102
Mainardes, R. M., Gremião, M. P. D., Brunetti, I. L., da Fonseca, L. M., & Khalil, N. M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21406 · Cited by 96
Essa, S., Rabanel, J., & Hildgen, P. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.039 · Cited by 94
Sharma, R., Muttil, P., Yadav, A. B., Rath, S. K., Bajpai, V. K., Mani, U., & Misra, A. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl533 · Cited by 94
Lin, H., Gebhardt, M., Bian, S., Kwon, K. A., Shim, C., Chung, S.-J., & Kim, D. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.043 · Cited by 92
Soderquist, R. G., Sloane, E. M., Loram, L. C., Harrison, J. A., Dengler, E. C., Johnson, S. M., Amer, L. D., Young, C. S., Lewis, M., Poole, S., et al. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0077-y · Cited by 92
Sant, S., Poulin, S., & Hildgen, P. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31800 · Cited by 93
Development of HIV Reservoir Targeted Long Acting Nanoformulated Antiretroviral Therapies
Edagwa, B., Zhou, T., McMillan, J., Liu, X. M., & Gendelman, H. E. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140826114135 · Cited by 87
Application of Outer Membrane Protein-Based Vaccines Against Major Bacterial Fish Pathogens in India
Maiti, B., Dubey, S., Munang’andu, H. M., Karunasagar, I., Karunasagar, I., & Evensen, Ø. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01362 · Cited by 84
Dry powder inhalable formulations for anti-tubercular therapy
Parumasivam, T., Chang, R. Y. K., Abdelghany, S. M., Ye, T. T., Britton, W. J., & Chan, H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.011 · Cited by 81
Nanoparticle based Drug Delivery Systems for Treatment of Infectious Diseases
Salouti, M., & Ahangari, A. (2014) · InTech eBooks · doi:10.5772/58423 · Cited by 78
Imbuluzqueta, E., Elizondo, E., Gamazo, C., Moreno‐Calvo, E., Veciana, J., Ventosa, N., & Blanco‐Prieto, M. J. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.11.031 · Cited by 75
Self-citationAkagi, T., Shima, F., & Akashi, M. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.049 · Cited by 73
Saito, E., Kuo, R., Kramer, K. R., Gohel, N., Giles, D. A., Moore, B. B., Miller, S. D., & Shea, L. D. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119432 · Cited by 72
Towards nanomedicines for neuroAIDS
Sagar, V., Pilakka‐Kanthikeel, S., Pottathil, R., Saxena, S. K., & Nair, M. (2014) · Reviews in Medical Virology · doi:10.1002/rmv.1778 · Cited by 71
Lecároz, C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl257 · Cited by 71
Wilson, D. S., Damo, M., Hirosue, S., Raczy, M. M., Brünggel, K., Diaceri, G., Quaglia-Thermes, X., & Hubbell, J. A. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0424-1 · Cited by 71
Luzardo-Alvarez, A., Blarer, N., Peter, K., Romero, J. F., Reymond, C., Corradin, G., & Gander, B. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.015 · Cited by 59
Self-citationLecároz, C., Campanero, M. Á., Gamazo, C., & Blanco‐Prieto, M. J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl258 · Cited by 59
Self-citationParumasivam, T., Leung, S. S. Y., Quan, D. H., Triccas, J. A., Britton, W. J., & Chan, H. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.03.024 · Cited by 56
Fredriksen, B. N., Sævareid, K. L., McAuley, L., Lane, M. E., Bøgwald, J., & Dalmo, R. A. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.08.087 · Cited by 56
Physicochemical Determinants in the Cellular Responses to Nanostructured Amorphous Silicas
Gazzano, E., Ghiazza, M., Polimeni, M., Bolis, V., Fenoglio, I., Attanasio, A., Mazzucco, G., Fubini, B., & Ghigo, D. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs128 · Cited by 56
Imbuluzqueta, E., Gamazo, C., Lana, H., Campanero, M. Á., Salas, D., Gil, A. G., Elizondo, E., Ventosa, N., Veciana, J., & Blanco‐Prieto, M. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00378-13 · Cited by 56
Self-citationMolecular aspects of microparticle phagocytosis by dendritic cells
Yoshida, M., & Babensee, J. E. (2006) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856206777996844 · Cited by 54
Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin
Lecároz, C., Gamazo, C., Renedo, M. J., & Blanco‐Prieto, M. J. (2006) · Journal of Microencapsulation · doi:10.1080/02652040600946886 · Cited by 54
Self-citationJilek, S., Ulrich, M., Merkle, H. P., & Walter, E. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000033012.16152.5d · Cited by 53
Self-citationMatijevic, M., Hedley, M. L., Urban, R. G., Chicz, R. M., Lajoie, C., & Luby, T. M. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.04.005 · Cited by 51
Prior, S. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh227 · Cited by 51
Self-citationEnhanced passive pulmonary targeting and retention of PEGylated rigid microparticles in rats
Kutscher, H. L., Chao, P., Deshmukh, M., Rajan, S. S., Singh, Y., Hu, P., Joseph, L. B., Stein, S., Laskin, D. L., & Sinko, P. J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.09.020 · Cited by 47
Nanomedicine to fight infectious disease
Rubey, K. M., & Brenner, J. S. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113996 · Cited by 49
Yadav, A. B., & Misra, A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00925-07 · Cited by 46
Recent advances in delivery systems for anti-HIV1 therapy
Lanao, J. M., Briones, E., & Colino, C. I. (2007) · Journal of drug targeting · doi:10.1080/10611860600942178 · Cited by 44
Takeuchi, I., Taniguchi, Y., Tamura, Y., Ochiai, K., & Makino, K. (2017) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2017.10.047 · Cited by 41
Use of lectin-functionalized particles for oral immunotherapy
Diesner, S. C., Wang, X.-Y., Jensen-Jarolim, E., Untersmayr, E., & Gabor, F. (2012) · Therapeutic Delivery · doi:10.4155/tde.11.146 · Cited by 40
Innate and adaptive immune responses in tissue engineering
Sefton, M. V., Babensee, J. E., & Woodhouse, K. A. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.12.008 · Cited by 40
Nanometrology: particle sizing and influence on the toxicological profile
Mota, W. S., Severino, P. B., Kadian, V., Rao, R., Zielińska, A., Silva, A. M., Mahant, S., & Souto, E. B. (2025) · Frontiers in Nanotechnology · doi:10.3389/fnano.2025.1479464 · Cited by 42
Mobarak, D. H., Salah, S., & Elkheshen, S. A. (2013) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2013.836293 · Cited by 38
Salari, F., Varasteh, A., Vahedi, F., Hashemi, M., & Sankian, M. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.09.011 · Cited by 37
Nanopolymersomes as potential carriers for rifampicin pulmonary delivery
Moretton, M. A., Cagel, M., Bernabeu, E., González, L., & Chiappetta, D. A. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.10.049 · Cited by 36
Gupta, M., Chashoo, G., Sharma, P. R., Saxena, A. K., Gupta, P. N., Agrawal, G. P., & Vyas, S. P. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400404p · Cited by 36
Imbuluzqueta, E., Lemaire, S., Gamazo, C., Elizondo, E., Ventosa, N., Veciana, J., Françoise Van Bambeke, A., & Blanco‐Prieto, M. J. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks172 · Cited by 36
Self-citationUpadhyay, T. K., Fatima, N., Sharma, A., Sharma, D., & Sharma, R. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1559180 · Cited by 35
Parikh, R. H., Dalwadi, S., Aboti, P. S., & Patel, L. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.13 · Cited by 35
Hasegawa, T., Hirota, K., Tomoda, K., Ito, F., Inagawa, H., Kochi, C., Soma, G., Makino, K., & Terada, H. (2007) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2007.06.017 · Cited by 35
Calcium‐Doped Organosilicate Nanoparticles as Gene Delivery Vehicles for Bone Cells
Moudgil, S., & Ying, J. Y. (2007) · Advanced Materials · doi:10.1002/adma.200701969 · Cited by 35
Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice
Prior, S. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki144 · Cited by 35
Self-citationTong, H.-I., Kang, W., Shi, Y., Zhou, G., & Lu, Y. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.03.028 · Cited by 35
Biggs, D. L., Lengsfeld, C., Hybertson, B. M., Ng, K., Manning, M. C., & Randolph, T. W. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00325-0 · Cited by 34
Vaccination Strategies against Malaria: novel carrier(s) more than a tour de force
Tyagi, R. K., Garg, N. K., & Sahu, T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.037 · Cited by 33
Khan, W., & Kumar, N. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.492524 · Cited by 33
Sousa-Batista, A. J., Lima, W. P., Arruda-Costa, N., Falcão, C. A. B., Ré, M. I., & Rossi‐Bergmann, B. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01822-17 · Cited by 32
Shahbaz, S. K., Varasteh, A., Koushki, K., Ayati, S. H., Mashayekhi, K., Sadeghi, M., Moghadam, M., & Sankian, M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106603 · Cited by 32
Verma, R. K., Agrawal, A. K., Singh, A. K., Mohan, M., Gupta, A., Gupta, P., Gupta, U. D., & Misra, A. (2013) · Tuberculosis · doi:10.1016/j.tube.2013.02.012 · Cited by 30
Yadav, A. B., Muttil, P., Singh, A. K., Verma, R. K., Mohan, M., Agrawal, A. K., Verma, A. S., Sinha, S. K., & Misra, A. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.03.001 · Cited by 30
Optimization of PLGA formulation containing protein or peptide‐based antigen: Recent advances
Hajavi, J., Ebrahimian, M., Sankian, M., Khakzad, M. R., & Hashemi, M. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36423 · Cited by 30
Gamazo, C., Prior, S., Lecároz, M. C., Vitas, A. I., Campanero, M. Á., Pérez, G., González, D., & Blanco‐Prieto, M. J. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.6.677 · Cited by 28
Self-citationO’Connor, G., Gleeson, L. E., Fagan-Murphy, A., Cryan, S., O’Sullivan, M. P., & Keane, J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.024 · Cited by 27
Korzhikov-Vlakh, V. A., Krylova, M., Sinitsyna, E., Ivan’kova, E. M., Averianov, I. V., & Tennikova, T. B. (2016) · Polymers · doi:10.3390/polym8120418 · Cited by 27
Effect of hesperidin conjugated with golden nanoparticles on phagocytic activity: In vitro study
Waheeb, H. M., Sulaiman, G. M., & Jabir, M. S. (2020) · AIP conference proceedings · doi:10.1063/5.0000159 · Cited by 25
Rosalia, R. A., Silva, A. L., Camps, M. G. M., Allam, A. A., Jiskoot, W., van der Burg, S. H., OSSENDORP, F. A., & Oostendorp, J. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1411-0 · Cited by 27
The internalization of fluorescence-labeled PLA nanoparticles by macrophages
Li, F., Zhu, A., Song, X., Ji, L., & Wang, J. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.033 · Cited by 25
Das, S., Khan, W., Mohsin, S., & Kumar, N. (2010) · Polymers for Advanced Technologies · doi:10.1002/pat.1710 · Cited by 24
Shrivastava, P., Gautam, L., Sharma, R. K., Dube, D., Vyas, S., & Vyas, S. P. (2020) · Journal of Microencapsulation · doi:10.1080/02652048.2020.1857861 · Cited by 22
Influence of the vehicle on the properties and efficacy of microparticles containing amphotericin B
Sánchez‐Brunete, J. A., Dea‐Ayuela, M. A., Rama, S., Bolás-Fernández, F., Alunda, J. M., Torrado, S., & Torrado, J. J. (2005) · Journal of drug targeting · doi:10.1080/10611860500097107 · Cited by 22
Tissue distribution of DNA-Hsp65/TDM-loaded PLGA microspheres and uptake by phagocytic cells
Trombone, A. P. F., Silva, C. L., de Almeida, L. P., Rosada, R. S., de Lima, K. M. C., Oliver, C., Jamur, M. C., & Coelho‐Castelo, A. A. M. (2007) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-5-9 · Cited by 21
Inhalable microparticles modify cytokine secretion by lung macrophages of infected mice
Sharma, R., Yadav, A. B., Muttil, P., Kajal, H., & Misra, A. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.11.003 · Cited by 20
Fatima, N., Upadhyay, T. K., Ahmad, F., Arshad, M., Kamal, M. A., Sharma, D., & Sharma, R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118851 · Cited by 20
Phagocytosis of synthetic particulate vaccine delivery systems to program dendritic cells
Thiele, L., Merkle, H. P., & Walter, E. (2002) · Expert Review of Vaccines · doi:10.1586/14760584.1.2.215 · Cited by 19
Self-citationVerma, R. K., Singh, A. K., Mohan, M., Agrawal, A. K., & Misra, A. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.34 · Cited by 18
Hirota, K., Hasegawa, T., Nakajima, T., Makino, K., & Terada, H. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.05.032 · Cited by 17
Murillo, M., Irache, J. M., Estevan, M., Goñi, M. M., Blasco, J. M., & Gamazo, C. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.11.008 · Cited by 17
Self-citationActivation of antigen-presenting cells by DNA delivery vectors
Meng, W. S., & Butterfield, L. H. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.8.1019 · Cited by 17
Applications of Nanotechnology in Vaccine Delivery
Singh, A., Misra, R., Mohanty, C., & Sahoo, S. K. (2010) · doi:10.1080/1943085x.2010.488198 · Cited by 16
Multipolymer microsphere delivery of SARS-CoV-2 antigens
Shahjin, F., Patel, M., Machhi, J., Cohen, J. D., Nayan, M. U., Yeapuri, P., Zhang, C., Waight, E. M., Hasan, M., Abdelmoaty, M. M., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.12.043 · Cited by 15
Haque, S., Swami, P. N., & Khan, A. U. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105082 · Cited by 15
Javiya, C., & Jonnalagadda, S. (2016) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2016.1151030 · Cited by 13
Various carrier system(s)- mediated genetic vaccination strategies against malaria - Retracted
Tyagi, R. K., Sharma, P., Vyas, S. P., & Mehta, A. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.4.499 · Cited by 13
RetractedLemke-Miltner, C. D., Geary, S. M., Joshi, V. B., & Salem, A. K. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.030 · Cited by 12
León-Rodriguez, L., Leiro-Vidal, J., Blanco-Méndez, J., & Luzardo-Álvarez, A. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.006 · Cited by 11
Innate and Adaptive Immune Responses in Tissue Engineering
Norton, L. W., & Babensee, J. E. (2009) · Springer eBooks · doi:10.1007/978-3-540-77755-7_50 · Cited by 11
Metadata
- Authors
- Prior, S., Gander, B., Blarer, N., Merkle, H. P., Subirá, M. L., Irache, J. M., & Gamazo, C.
- Affiliations
- Universidad de Navarra (ES)
- ETH Zurich (CH)
- Corresponding author
- Gamazo, Carlos
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 15
- Issue
- 2
- Pages
- 197-207
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2057572412
- Cited by
- 138
- References
- 42
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 6 · 2019: 4 · 2018: 3 · 2017: 1 · 2016: 9 · 2015: 5 · 2014: 9 · 2013: 8 · 2012: 6
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Pharmaceutical Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- polylactic acid, poly(lactic-co-glycolic acid), microspheres, phagocytosis, monocyte/macrophage activation, polymer hydrophobicity, opsonization, respiratory burst, gentamicin sulfate, intracellular drug delivery, J774 cells, blood monocytes
- MeSH terms
- Polylactic Acid-Polyglycolic Acid Copolymer, Aminoglycosides, Animals, Biocompatible Materials, Cells, Cultured, Gentamicins, Humans, Macrophage Activation, Macrophages, Microspheres, Monocytes, Phagocytosis, Polyesters, Polyglycolic Acid, Polymers, Drug Delivery Systems, Respiratory Burst, Lactic Acid, Mice, Static Electricity, Hydrophobic and Hydrophilic Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review